Robert Tarran
Principal investigator, leads ELDEC PHARMACEUTICALS INC..
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2020First federal award
$2.9MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $2.9M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 23, 2022 | NIH | STTR Phase I Novel Peptide Fusion Inhibitors for the Treatment of COVID-19 | $300K | ELDEC PHARMACEUTICALS INC. |
| Aug 23, 2022 | NIH | STTR Phase I Novel Peptide Fusion Inhibitors for the Treatment of COVID-19 | $300K | ELDEC PHARMACEUTICALS INC. with UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL |
| Jun 28, 2022 | NIH | STTR Phase II ELD607 Orai1 Antagonist Increases Bacterial Clearance from the Lung | $988K | ELDEC PHARMACEUTICALS INC. |
| Jul 19, 2021 | NIH | STTR Phase II ELD607 Orai1 Antagonist Increases Bacterial Clearance from the Lung | $1000K | ELDEC PHARMACEUTICALS INC. |
| Jun 22, 2020 | NIH | STTR Phase II ELD607 Orai1 Antagonist Increases Bacterial Clearance from the Lung | $300K | ELDEC PHARMACEUTICALS INC. |
Peer ranks
Federal funding#652
Awards as PI#417
Patents#273
Companies
- ELDEC PHARMACEUTICALS INC.Leads (SEC Form D) · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.